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Abstract
Objective: To evaluate the generalizability of recently developed clinical prediction rules for the prognosis of shoulder pain in general
practice.
Study Design and Setting: A large research program, consisting of a prognostic cohort study and three randomized controlled trials
with 6 months follow-up, was carried out in The Netherlands. The clinical prediction rules were derived from the results of the prognostic
cohort study (n 5 587). The main outcome measure was persistent symptoms at 6 weeks or 6 months. The control groups of the trials who
received usual care were merged (n 5 212), and used to validate the prediction rules by studying calibration and discrimination.
Results: The prediction rule for short-term outcome showed reasonable calibration and discriminative ability in this validation cohort.
The area under the receiver operating characteristic curve (AUC) was 0.72 compared to 0.74 in the derivation cohort. The prediction rule for
long-term outcome performed less well. Discriminative ability (AUC) decreased to 0.56 in the validation cohort compared to 0.67 in the
derivation cohort.
Conclusion: The prediction rule for the short-term (6 weeks) prognosis showed good generalizability. The prediction rule for the long-
term prognosis showed poor generalizability.  2007 Elsevier Inc. All rights reserved.
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Shoulder pain is common with a 1-year prevalence rang-
ing between 5% and 47% [1e5]. The prevalence in the gen-
eral population in The Netherlands has recently been
estimated at 17% [6]. The annual incidence of consultation
for a new episode of shoulder pain in Dutch general prac-
tice ranges between 12 and 25/1000/yr [3,6e8]. Shoulder
pain has an unfavorable outcome in many patients. About
40e50% of all patients who present with a new episode
of shoulder pain in primary care report persistent symptoms
after 6e12 months [9e11].
We developed clinical prediction rules consisting of
a limited number of (easily measurable) prognostic factors
* Corresponding author. Tel.: þ31-20-652-1172; fax: þ31-20-652-
1141.
E-mail address: a.c.kuijpers@hva.nl (T. Kuijpers).0895-4356/07/$ e see front matter  2007 Elsevier Inc. All rights reserved.
doi: 10.1016/j.jclinepi.2006.11.015to predict the risk of persistent shoulder symptoms at the
short (6 weeks) and long term (6 months). Such information
may also support decisions regarding treatment and referral
of patients. The performance (i.e., calibration and discrim-
ination) of the prediction rules was evaluated in the devel-
opment study [12]. Calibration refers to what extent the
observed frequencies agree with the predicted probabilities.
Discrimination refers to the ability to distinguish between
a patient with persistent symptoms and a patient without
persistent symptoms.
Before considering implementation of the prediction
rules in clinical practice their generalizability needs to be
tested [13e15]. Generalizability refers to the performance
in patients drawn from a different but comparable popula-
tion [13]. Our objective was therefore to evaluate the per-
formance of our clinical prediction rules for the prognosis
of shoulder pain in a different population of patients with
shoulder pain in primary care.
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2.1. Dutch shoulder study
The Dutch Shoulder Study (DSS) is a comprehensive
cohort study, carried out between January 2000 and May
2005. The DSS consists of one prognostic cohort study
and three randomized controlled trials, which were carried
out alongside each other. Between January 2001 and June
2003, 103 general practitioners (GPs) recruited patients at
first consultation for a new episode of shoulder complaints
in three geographic areas in The Netherlands (Amsterdam,
Groningen, and Maastricht). All patients in the DSS had to
meet the same general inclusion criteria, and specific addi-
tional inclusion criteria if eligible for a trial (Table 1). For
the prognostic cohort study no additional inclusion criteria
were specified. Data of the prognostic cohort study were
used to derive the prediction rules. Data of the control
groups of the three trials were used to study the generaliz-
ability of the rules.
The Groningen Manipulation Study [16,17] studies the ef-
fectiveness of manipulative therapy for the shoulder girdle in
addition to usual care. In two other trials, a Graded Exercise
Therapy [18] and an Education and Activation Program [19],
respectively, were studied. Patients in the control groups of
the trials received usual care, similar to the patients in the
cohort study.
Baseline and follow-up assessments for all patients in
the DSS were identical. The outcome was measured by
postal questionnaires at 6 weeks, 3, and 6 months. The pri-
mary outcome measure was ‘‘patient perceived recovery’’
measured on an 8-point scale (1e3 5 very much/much/
slight deterioration; 4 5 no change; 5e7 5 slight/much/
very much improvement; 8 5 complete recovery) [17,20].
Persistent symptoms were defined as any deterioration, no
change, slight or much improvement. Secondary outcome
Table 1
Selection criteria for the DSS
General inclusion criteria
Patients 18 yr of age or older
Not consulted GP or received any form of treatment for the afflicted
shoulder in the preceding 3 mo
Sufficient knowledge of the Dutch language
Specific inclusion criteria trials
Groningen Manipulation Study (GMO)
Dysfunction of the cervicothoracic spine and adjacent ribs with
accompanying pain or restricted movement
Graded Exercise Therapy Study (GET)
Duration of complaints O3 mo
Education and Activation Program (EAP)
Duration of complaints !3 mo
Exclusion criteria
Severe physical or psychological conditions (i.e., fractures or luxation in
the shoulder region; rheumatic disease; neoplasm; neurological or
vascular disorders; dementia)measures were shoulder disability, measured with the 16-
item shoulder disability questionnaire (0e100) [21], pain
(0e10 numeric rating scale) [20], and severity of the main
complaint (0e10 numeric rating scale) [22].
2.2. Management of shoulder pain
All participants in the cohort study and the trial partici-
pants randomized to the control groups, received standard-
ized treatment according to the 1999 version of the Dutch
guidelines for shoulder disorders issued by the Dutch Col-
lege of General Practitioners [23,24]. The guidelines rec-
ommend giving information on the prognosis of shoulder
pain, advice regarding provoking activities, and stepwise
treatment consisting of paracetamol, nonsteroidal antiin-
flammatory drugs (NSAIDs), corticosteroid injection, or re-
ferral for physiotherapy. The GP made the decision
regarding the content of treatment based on duration and
severity of pain and disability. The participating GPs were
educated and trained to apply treatment according to this
guideline.
2.3. Prediction rules
The prediction rules for persistent symptoms (yes/no) af-
ter 6 weeks and 6 months were developed using informa-
tion from the 587 patients of the derivation cohort.
Sociodemographic variables, disease characteristics (i.e.,
pain intensity, disability, duration of complaints, onset, co-
morbidity), physical workload, psychosocial factors, and
results of a physical examination were used to derive the
prediction rules. We tested the internal validity with boot-
strapping techniques [13]. The calibration of the prediction
rules was adequate. The discriminative ability was satisfac-
tory with area under the receiver operating characteristic
(ROC) curve (AUC) of 0.74 (95% confidence interval
[CI] 0.70, 0.79) at 6 weeks and 0.67 (95% CI 0.63, 0.71)
at 6 months. Fig. 1 presents the prediction rules as score
charts, development of which has been described in detail
elsewhere [12].
2.4. Analysis
We compared the baseline characteristics of the deriva-
tion and validation cohort to assess differences of >10%.
This cutoff point was used as a rule of the thumb to explore
whether there are differences between the cohorts that may
explain a reduction in the performance of the prediction
rule when tested in the validation cohort. The performance
of the prediction rules was tested in the validation cohort by
evaluating their calibration and discrimination. Calibration
was assessed by plotting the predicted probabilities of per-
sistent symptoms according to the prediction rule, against
the observed frequencies. For this, patients were grouped
into quintiles according to their predicted probability of
persistent symptoms. The prevalence of the endpoint within
each quintile equals the observed frequency. A more formal
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The predicted probability of persistent symptoms at 6 weeks was determined by P=1/[1+ exp – (–1.19 + 0.64 × duration
of complaints 6-12 weeks + 0.95 × duration of complaints >3 months + 0.59 × gradual onset  + 0.85 × concomitant
psychological complaints  + 0.68 × repetitive movements  + 0.13 × shoulder pain + 0.09 × neck pain score at physical
examination)]. 
Score chart for prediction of persistent shoulder symptoms at 6 months
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The predicted probability of persistent symptoms at 6 months was determined by P=1/[1+ exp – (–1.48 + 0.34 × duration
of complaints 6-12 weeks + 0.64  ×  duration of complaints >3 months + 0.37 × gradual onset  + 0.50 × concomitant low
back pain + 0.08 ×  shoulder pain + 0.04 × shoulder pain score at physical examination)]. 
Instruction
If a predictor is scored positively, the given weight needs to be filled in. Subsequently the scores are added to calculate
the ‘Total score’. From the table next to the score chart the risk (%) of persistent symptoms for an individual patient can
be determined.
Fig. 1. Prognostic score charts for prediction of persistent symptoms at 6 weeks and 6 months.indication of calibration can be obtained by fitting a logistic
regression model with the logodds of the predicted risks as
only covariate. This model has an intercept and a slope. If
predicted risks and observed frequencies are in agreement,
the intercept is equal to 0 and the slope equal to 1.
The AUC was used to assess the discriminative ability of
the model. An AUC of 0.5 indicates no discrimination
above chance, whereas an AUC of 1.0 indicates perfect dis-
crimination. Because the discriminative ability of a rule is
related to the homogeneity of the sample in which the rule
is applied, we estimated the maximum attainable AUC.
Using the predicted risks of the patients in the validation
cohort, outcomes were generated with Monte Carlo
Simulation [25,26]. This mimics the situation that the pre-
dictions were correct, that is, the model is perfectly cali-
brated. The AUC that was estimated for the predictedrisks and generated outcomes was considered the maximum
attainable AUC for the validation sample.
Furthermore, to gain insight into the performance of our
prediction rules, we estimated the multivariable logistic re-
gression coefficients for each of the predictors of our predic-
tion rule in the validation cohort. This analysis shows which
of the different elements of the rule are the strongest predic-
tors of persistent shoulder pain in the validation cohort.
3. Results
3.1. Study population
Table 2 presents the baseline characteristics of the deri-
vation cohort and validation cohort. Patients in the
950 T. Kuijpers et al. / Journal of Clinical Epidemiology 60 (2007) 947e953validation cohort clearly showed a longer duration of com-
plaints at baseline (13% less often complaints between
0 and 6 weeks, and 14% more often complaints O3
months), and reported 10% more neck complaints in the
past in comparison with the derivation cohort.
3.2. Course of symptoms
Table 2 shows that more patients in the validation cohort
reported persistent symptoms after 6 weeks (89% vs. 70%)
and 6 months (69% vs. 46%), compared to the derivation
cohort. Nevertheless, patients in the derivation and valida-
tion cohort reported similar levels of pain and disability
at the different time points. Likewise, patients reporting re-
covery in the validation cohort and in the derivation cohort
showed similar low levels of pain (!1 point), disability
(!13 points), and severity of the main complaint (!1
point).3.3. Management of shoulder pain
At baseline most patients in the derivation cohort
(n 5 423, 72%) received a wait and see policy, paraceta-
mol, or NSAIDs. Furthermore, 68 patients (12%) received
an injection with corticosteroid, 58 patients (10%) were re-
ferred for physiotherapy, and 28 patients (6%) received
other therapies. In the validation cohort, 141 patients
(83%) received a wait and see policy, paracetamol, or
NSAIDs; 9 patients (5%) received an injection; 11 patients
(7%) were referred for physiotherapy; and 8 patients (5%)
received other therapies.
3.4. Performance
Fig. 2 shows the calibration of the predictions. For 6
weeks, the plotted points were rather close to the 45 line,
although most predictions slightly underestimated theTable 2
Description of baseline characteristics and outcome measures at 6 wk and 6 mo of patients with shoulder pain in the derivation (n 5 587) and validation




Age (yr); mean (SD) 51 (14) 51 (12)
Gender: male; n (%) 292 (50) 92 (44)
Disease characteristics
Duration of complaints; n (%)
0e6 wka 205 (35) 46 (22)
7e12 wk 139 (24) 49 (23)
O3 mo 242 (41) 115 (55)
Gradual onset (vs. acute); n (%) 363 (62) 144 (69)
Precipitating cause; n (%)
Strain/overuse: usual activities 138 (24) 58 (28)
Shoulder complaints in the past; n (%) 348 (62) 136 (65)
Neck complaints in the past; n (%) 296 (51) 128 (61)
Comorbid psychological complaints; n (%) 55 (9) 20 (10)
Concomitant musculoskeletal complaints; n (%)
Neck/high back 209 (36) 85 (41)
Low back pain 139 (24) 59 (28)
Upper extremity 174 (30) 76 (36)
Shoulder pain (0e10); mean (SD) 4.8 (2.3) 5.3 (2.2)
Shoulder disability (0e100); mean (SD) 60 (24) 62 (24)
Physical examination
Shoulder pain score (0e18); median (IQR) 4 (2e4) 7 (4e7)
Neck pain score (0e18); median (IQR) 0 (0e0) 2 (0e2)
Physical factors
Dynamic physical workload (0e5); median (IQR) 1 (1e2) 1 (0e1)
Repetitive movements; n (%) 384 (65) 151 (73)
Outcome measures 6 wk 6 mo 6 wk 6 mo
Persistent symptoms; n (%) 340 (70) 249 (46) 161 (89) 125 (69)
Paina (0e10); mean (SD) 4.3 (2.1) 4.1(2.3) 4.3 (2.1) 4.0 (2.0)
Shoulder disabilitya (0e100); mean (SD) 53.0 (25.5) 52.2 (26.7) 56.0 (25.6) 54.4 (27.2)
Severity of main complainta (0e10); mean (SD) 4.8 (2.6) 5.0 (2.8) 4.9 (2.5) 5.6 (2.6)
SD, standard deviation; IQR, interquartile range.
a Mean and SD presented for group reporting persistent symptoms.
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cept of 0.44 in a model, using the logodds of the predicted
probabilities as only covariate. The intercept above 0 con-
firms that the predicted probabilities were generally too
low. The slope of the model was 1.1, which is close to 1.
For 6 months, the plotted points were further away from
the 45 line, demonstrating a rather poor calibration of the
model. This is confirmed by an intercept of 0.39 (not close
to 0) and a slope of 0.43 (not close to 1).
The discriminative ability (AUCs) of the prediction rules
was 0.72 (95% CI 0.63, 0.82) at 6 weeks, and 0.57 (95% CI
0.48, 0.66) at 6 months. The Monte Carlo Simulation
showed a maximum attainable AUC of 0.70 at 6 weeks,
and 0.64 at 6 months.
Table 3 shows the estimates of the regression coeffi-
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Fig. 2. Calibration plots showing the observed probabilities vs. the pre-
dicted probabilities for persistent symptoms at 6 weeks (n 5 175) and 6
months (n 5 180) in the validation cohort.validation cohort. A duration of complaints O3 months
and repetitive movements were strong predictors of persis-
tent symptoms at 6 weeks. For long-term outcomes, a dura-
tion O3 months and a gradual onset seemed strongly
related with persistent symptoms at 6 months.
4. Discussion
The performance of the prediction rule for the short-
term (6 weeks) prognosis of shoulder pain in the validation
cohort was satisfactory. There are no generally accepted
cutoffs for the AUC, although a value of 0.80 or higher is
sometimes used as a rule of the thumb to indicate good per-
formance. Calibration and discriminative ability were rea-
sonable, and similar to that found in the derivation cohort
(AUC 5 0.74 in derivation cohort, and AUC 5 0.72 in val-
idation cohort). The prediction rule for long-term (6
months) outcome showed poor calibration and discrimina-
tion. The AUC decreased from 0.67 in the derivation cohort
to 0.57 in the validation cohort, not much more than a flip
of a coin (AUC 5 0.50), which means that the performance
of the long-term prediction rule was disappointing.
RCTs usually include more homogeneous patient popu-
lations. This may have affected the performances of the
prediction rule in the validation cohort, but at the same time
demonstrates the applicability of the rule in a different set-
ting and slightly different population. The patients in the
validation cohort differed from the derivation cohort re-
garding several aspects. In general, the shoulder complaints
from the patients in the validation cohort were more severe
(Table 3). They showed a longer duration of symptoms,
which is an important predictor of outcome [12], and re-
ported more neck complaints in the past. This may indicate
that we have tested the performance of the prediction rule
in patients who, on average, were more advanced in their
disease process or who may have had a somewhat different
type of shoulder problem (which has been described as
spectrum transportability [13]). More severe complaints at
baseline may have resulted in more frequent reports of per-
sistent symptoms (Table 3). Another possible explanation
for the higher occurrence of persistent symptoms could
be that the validation cohort more often received a wait
and see policy (83% vs. 72%) and were less frequently
treated with local infiltration of a corticosteroid (5% vs.
12%).
It has been reported that a validation cohort should min-
imally consist of 100 events [26]. The event rate was suffi-
cient for the prediction rule for 6 months. However, the
performance of the rule for 6 weeks was better than the rule
for 6 months. This may indicate that the lack of sufficient
events may be of less importance than the relative weak as-
sociations between baseline characteristics and outcome.
Differences in prognosis between the derivation and val-
idation cohort may have substantially altered the calibration
of our prediction rules in the validation cohort, especially
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Prediction rules for persistent shoulder symptoms at 6 wk and 6 mo after first consultation
Predictor Scale
Derivation Validation
b 95% CI b 95% CI
6 weeks
Duration of complaints
0 to 6 wka d d
7 to 12 wk (yes/no) 0.64 0.1 to 1.2 0.42 0.9 to 1.7
O3 mo (yes/no) 0.95 0.4 to 1.5 1.67 0.2 to 3.1
Gradual onset (yes/no) 0.59 0.1 to 1.1 0.36 0.7 to 1.4
Concomitant psychological complaints (yes/no) 0.85 0.1 to 1.9 0.74 1.5 to 3.0
Repetitive movements (yes/no) 0.68 0.2 to 1.1 1.05 0.1 to 2.2
Shoulder pain (0 to 10) 0.13 0.0 to 0.2 0.06 0.2 to 0.3
Neck pain score at physical examination (0 to 18) 0.09 0.0 to 1.0 0.03 0.1 to 0.2
6 months
Duration of complaints
0 to 6 wka d d
7 to 12 wk (yes/no) 0.34 0.1 to 0.8 0.10 1.3 to 1.1
O3 mo (yes/no) 0.64 0.2 to 0.1 1.24 0.1 to 2.6
Gradual onset (yes/no) 0.37 0.0 to 0.6 0.70 0.3 to 1.7
Concomitant low back pain (yes/no) 0.50 0.1 to 0.9 0.01 1.1 to 1.2
Shoulder pain (0 to 10) 0.08 0.0 to 0.2 0.04 0.2 to 0.3
Shoulder pain score at physical examination (0 to 18) 0.04 0.0 to 0.1 0.09 0.0 to 0.2
The b values are derived from a multiple logistic regression analysis. The b values for the validation cohort are derived from the results of a multiple
logistic regression analysis conducted with the predictors from the derivation cohort.
a Reference category.for the long term. The reason for this is that statistical
models are calibrated to the overall outcome prevalence.
For a substantial part, this prevalence is determined by
the characteristics of the patient population. As long as
the overall prevalence is explained by predictors which
are included in the prediction rule, the model will still be
well calibrated. This may have resulted in a reasonable cal-
ibration of our short-term prediction rule, despite differ-
ences at baseline between the derivation and validation
cohort regarding important predictors, that is, duration of
complaints and repetitive movement. The poor perfor-
mance of the prediction rule for long-term outcomes may
be explained by patient characteristics which are not docu-
mented in this study, but yet strongly influenced outcome in
the validation cohort.
The maximum attainable AUC for the short term of 0.70
strengthens our findings of adequate discriminative ability
of this rule. Calibration was reasonable, although an inter-
cept of 0.44 showed that the risk of persistent shoulder pain
was generally underestimated (see also Fig. 2). For the long
term, a substantially lower maximum attainable AUC of
0.64 differed considerably from the achieved AUC of
0.57. This indicated a model with poor discriminative abil-
ity. Regression coefficients were generally too high, and in-
sufficient shrinking of the regression coefficients had been
achieved in the development stage of the prediction rule.
Justice et al. [13] stated that perhaps the most difficult test
of discrimination occurs when the spectrum of a disease
narrows from both sides; that is, the test sample includes
many patients who have an illness of intermediate severity
and very few who are either severely ill or not very ill at all.This could partly explain the poor performance of our long-
term prediction rule as most observed probabilities of per-
sistent symptoms were distributed between 0.5 and 0.7
(Fig. 2). This reflects a homogeneous population resulting
in a low maximum attainable AUC of 0.64.
We developed prediction rules to predict the prognosis
of shoulder pain in general practice. Most elements of the
prediction rules were derived from a questionnaire, filled
out by the patient. Our prediction rule might be applicable
in primary care populations elsewhere, provided that man-
agement of shoulder pain is largely comparable. However,
given the fact that performances of prediction rules may
vary across populations, their predictive validity should ide-
ally be tested when implemented in other settings or coun-
tries. If these prediction rules would be implemented in
daily practice, it is the GP who asks the questions and cal-
culates the risk by using a score chart. Or in a more sophis-
ticated way, enters the responses into a personal computer
or personal digital assistant, which calculates the risk of
persistent symptoms. So, future research should also evalu-
ate the methodologic transportability of the prediction rules
(i.e., performance when data are collected by using alterna-
tive methods [13]) in a new sample of patients. And perhaps
most importantly, the clinical usefulness of these instru-
ments should be established: can the prediction rules be
helpful to the clinician when making decisions in the man-
agement of patients with shoulder pain, for example,
whether or not to consider additional diagnostic testing, start
a certain treatment or refer the patient to secondary care [15].
Duration has indeed been shown to be an important pre-
dictor in previous research [27]. Our prediction, however,
953T. Kuijpers et al. / Journal of Clinical Epidemiology 60 (2007) 947e953includes a few other predictors that may help to estimate
prognosis in primary care patients with shoulder pain.
The main objective of this study, however, was not only
to identify prognostic indicators of outcome, but also to
present prognostic information in a simple format that en-
ables the computation of the risk of a poor outcome in in-
dividual patients. This is the first time that a prediction rule
for shoulder pain has been developed and tested.
In conclusion, the prediction rule for the short-term (6
weeks) prognosis of shoulder pain in general practice showed
adequate generalizability in the validation cohort. The long-
term outcomes (6 months) seems difficult to make accurate
predictions of persistent shoulder pain in this population.
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